Formulary Management of the Protease Inhibitors Boceprevir and Telaprevir for Chronic Hepatitis C Virus

BACKGROUND: Hepatitis C virus (HCV) is the most common chronic blood borne illness in the United States. The incidence of acute hepatitis C in the United States peaked near 50,000 cases in the late 1980s but has stabilized since 2003 to less than 5,000 cases annually. The combination of pegylated in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tungol, Alexandra, Rademacher, Kellie, Schafer, Jeremy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2011
Materias:
Formulary Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437935/
https://www.ncbi.nlm.nih.gov/pubmed/22050393
http://dx.doi.org/10.18553/jmcp.2011.17.9.685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437935/
https://www.ncbi.nlm.nih.gov/pubmed/22050393
http://dx.doi.org/10.18553/jmcp.2011.17.9.685

Ejemplares similares